Search results for "Anticoagulation"
Lifestyle, treatment changes for afib
A new atrial fibrillation guideline focuses on early rhythm control and lifestyle changes such as physical activity and weight loss to slow or disrupt the course of the disease.
https://immattersacp.org/archives/2024/09/lifestyle-treatment-changes-for-afib.htm
1 Sep 2024
MKSAP Quiz: Leg swelling, pain of 1 week's duration
A 48-year-old woman is evaluated in the emergency department for right leg swelling and pain of 1 week's duration. She reports no recent surgery, injuries, periods of immobility, or long airplane flights. Following a physical exam and ultrasound, what is the most appropriate management?
https://immattersacp.org/weekly/archives/2024/05/28/3.htm
28 May 2024
Amiodarone increases bleeding compared with flecainide or sotalol in patients on anticoagulant therapy
A retrospective analysis of Medicare patients who started an anticoagulant and then amiodarone found that they had a 44% increased risk for bleeding-related hospitalization compared to those on other antiarrhythmics and that this risk was higher with rivaroxaban than apixaban.
https://immattersacp.org/weekly/archives/2023/05/23/1.htm
23 May 2023
Parsing periop predicaments
Due to a lack of evidence for best perioperative procedures, clinicians have debated for decades how to address circumstances such as stroke or atrial fibrillation.
https://immattersacp.org/archives/2024/07/parsing-periop-predicaments.htm
1 Jul 2024
Discontinuing OAC associated with heightened risk of recurrent stroke, study finds
Among patients with atrial fibrillation prescribed oral anticoagulation (OAC) after a stroke, recurrent stroke rates were 13.4% versus 6.8% in those who did and did not discontinue OAC therapy, a Danish study found.
https://immattersacp.org/weekly/archives/2024/07/02/4.htm
2 Jul 2024
Patients with provoked VTE often on anticoagulation longer than recommended
Three variables were associated with receiving anticoagulation for longer than three months after a provoked venous thromboembolism (VTE): direct oral anticoagulant use, history of VTE, and history of myocardial infarction.
https://immattersacp.org/weekly/archives/2022/11/01/4.htm
1 Nov 2022
Apixaban appears safer than rivaroxaban, warfarin in cirrhosis with atrial fibrillation
Patients who initiated rivaroxaban or warfarin had significantly higher rates of major hemorrhagic events than those taking apixaban, a retrospective study of U.S. patients with cirrhosis and nonvalvular atrial fibrillation found.
https://immattersacp.org/weekly/archives/2024/07/09/1.htm
9 Jul 2024
Long-term anticoagulation after first unprovoked VTE associated with considerable bleeding risk
Results from a systematic review and meta-analysis provide a framework for clinicians and patients to balance the benefits and harms of extended anticoagulation for unprovoked venous thromboembolism (VTE).
https://immattersacp.org/weekly/archives/2021/09/14/4.htm
14 Sep 2021
Patients with atrial fibrillation likely to underestimate bleeding risks of anticoagulants
Women were significantly less likely than men to underestimate their bleeding risk, and a history of bleeding was associated with a threefold increased likelihood of inaccurate perception of bleeding risk, according to a study of atrial fibrillation patients.
https://immattersacp.org/weekly/archives/2021/08/24/2.htm
24 Aug 2021
Real-world data quantifies injuries from potentially hepatotoxic medications
Incidence rates of severe acute liver injury ranged from 0 events per 10,000 person-years with candesartan and minocycline to 86.4 events per 10,000 person-years with stavudine among patients without preexisting liver or biliary disease, according to Veterans Affairs data.
https://immattersacp.org/weekly/archives/2024/06/25/2.htm
25 Jun 2024